Ajer Jeffrey Robert
- SEC CIK
- 0001557533
No open-market purchases or sales filed in the past year.
Current role at each company
- NKTR Nektar TherapeuticsDirectoras of Sep 25, 2026
- VRDN Viridian Therapeutics, Inc.Directoras of Jul 2, 2026
- BMRN Biomarin Pharmaceutical IncEVP, Chief Commercial Officeras of May 6, 2024
Open-market trades in the past year
Open-market purchases (P) and sales (S) filed in the last 365 days, not counting derivative securities or duplicate filings. Values leave out price outliers.
- Bought
- –
- 0 filings
- Sold
- –
- 0 filings
- Net
- –
- Bought minus sold
- Companies
- 0
- With open-market trades
Trades
Every Form 4 that lists Ajer Jeffrey Robert as a reporting owner, including filings made jointly with others, grouped by company. Each row adds up one type of transaction in one filing. Only open-market purchases (P) and sales (S) are shown by default.
BMRN Biomarin Pharmaceutical Inc
EVP, Chief Commercial Officer11 trades
| Filed (ET) | Trade date | Filing delay | Insider | Transaction | Shares | Avg price | Value | Holding change | Flags |
|---|---|---|---|---|---|---|---|---|---|
| May 6, 2024 (view filing) | May 2 | 4 days | Ajer Jeffrey RobertEVP, Chief Commercial Officer | SSale | −5.00K | $82.91 | −$414.6K | −7.0%66.8K after | 10b5-1 |
| Mar 7, 2024 (view filing) | Mar 5 | 2 days | Ajer Jeffrey RobertEVP, Chief Commercial Officer | SSale | −4.00K | $87.07 | −$348.3K | −4.1%94.0K after | 10b5-1 |
| Aug 17, 2023 (view filing) | Aug 16 | 1 day | Ajer Jeffrey RobertEVP, Chief Commercial Officer | SSale | −5.00K | $90.00 | −$450.0K | −7.6%60.8K after | 10b5-1 |
| Jan 27, 2023 (view filing) | Jan 25 | 2 days | Ajer Jeffrey RobertEVP, Chief Commercial Officer | SSale | −49.0K | $115.69 | −$5.67M | −54.4%41.1K after | 2 lots |
| Nov 4, 2022 (view filing) | Nov 2 | 2 days | Ajer Jeffrey RobertEVP, Chief Commercial Officer | SSale | −3.00K | $86.12 | −$258.4K | −6.8%41.1K after | |
| Aug 12, 2022 (view filing) | Aug 11 | 1 day | Ajer Jeffrey RobertEVP, Chief Commercial Officer | SSale | −3.00K | $95.62 | −$286.9K | −6.4%44.1K after | |
| May 31, 2022 (view filing) | May 26 | 5 days | Ajer Jeffrey RobertEVP, Chief Commercial Officer | SSale | −1.31K | $78.94 | −$103.3K | −2.4%54.1K after | |
| Apr 14, 2022 (view filing) | Apr 13 | 1 day | Ajer Jeffrey RobertEVP, Chief Commercial Officer | SSale | −1.18K | $82.47 | −$97.3K | −2.1%55.1K after | |
| Mar 31, 2022 (view filing) | Mar 29-30 | 2 days | Ajer Jeffrey RobertEVP, Chief Commercial Officer | SSale | −3.00K | $79.49 | −$238.4K | −5.1%56.3K after | 2 lots |
| Mar 24, 2022 (view filing) | Mar 22-23 | 2 days | Ajer Jeffrey RobertEVP, Chief Commercial Officer | SSale | −8.20K | $81.58 | −$669.1K | −12.2%59.3K after | 2 lots |
NKTR Nektar Therapeutics
Director3 trades
| Filed (ET) | Trade date | Filing delay | Insider | Transaction | Shares | Avg price | Value | Holding change | Flags |
|---|---|---|---|---|---|---|---|---|---|
| Sep 20, 2023 (view filing) | Sep 18 | 2 days | Ajer Jeffrey RobertDirector | SSale | −4.36K | $0.69 | −$3.01K | −11.3%34.2K after | |
| Sep 26, 2022 (view filing) | Sep 23 | 3 days | Ajer Jeffrey RobertDirector | SSale | −4.20K | $3.16 | −$13.3K | −9.8%38.5K after | |
| Sep 24, 2021 (view filing) | Sep 22 | 2 days | Ajer Jeffrey RobertDirector | SSale | −3.67K | $17.78 | −$65.2K | −10.1%32.5K after |